Cepheid Overview

  • Founded
  • 1996

  • Status
  • Acquired/​Merged

  • Employees
  • 4,972

  • Latest Deal Type
  • Grant

  • Investors
  • 1

Cepheid General Information


Developer of diagnostic systems focused to improve patient outcomes by enabling access to molecular testing. The company's technology offers rapid on-demand genetic, sexual health, SARS-CoV-2, virology, oncology and critical infectious disease testing options, thereby helping laboratories and hospitals in making faster clinical decisions as opposed to culture or batch-based PCR testing.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Parent Company
Primary Office
  • 904 Caribbean Drive
  • Sunnyvale, CA 94089
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cepheid Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 22-Oct-2021 Completed Generating Revenue/Not Profitable
9. Grant 30-Jul-2021 0000 Completed Generating Revenue/Not Profitable
8. Grant 01-Sep-2020 000 Completed Generating Revenue/Not Profitable
7. Grant 01-Feb-2020 00.00 Completed Generating Revenue/Not Profitable
6. Merger/Acquisition 04-Nov-2016 000 000.00 000 Completed Generating Revenue/Not Profitable
5. Grant 13-Nov-2014 00.00 000.00 Completed Generating Revenue/Not Profitable
4. IPO 21-Jun-2000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 06-Mar-2000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 30-Nov-1998 $8.2M Completed Generating Revenue
1. Early Stage VC (Series B) 01-Apr-1998 $8.2M $8.2M Completed Generating Revenue
To view Cepheid’s complete valuation and funding history, request access »

Cepheid Comparisons

HQ Location
Total Raised
Post Valuation
Developer of diagnostic systems focused to improve patient outcomes by enabling access to molecular testing. The company
Diagnostic Equipment
Sunnyvale, CA
4,972 As of 2022


illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pro
0000000000 000000000
Uppsala, Sweden
000 As of 0000
00000000 00000


aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
0000000000 000000000
Thousand Oaks, CA
00 As of 0000
00.00 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cepheid Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Q-linea Formerly VC-backed Uppsala, Sweden 000 00000 00000000 00000
00000000 00 Formerly VC-backed Thousand Oaks, CA 00 000.00 00000000 000.00
000000000 Formerly PE-Backed Billerica, MA 000 00000 00000000 00000
0000000 0000000 Corporate Backed or Acquired Brea, CA 00000 000000&0
00000 Formerly VC-backed Fremont, CA 000 00000 00000000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Cepheid Patents

Cepheid Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220298572-A1 Compositions and methods for discriminating bacterial and viral infections in a human subject Pending 16-Mar-2021 0000000000
US-20220224259-A1 Encoderless motor with improved quantization and methods of use and calibration Pending 13-Jan-2021 000000000 0
US-20220253079-A1 Thermal control device and methods utilizing temperature distribution modeling Pending 13-Jan-2021 00000000000
US-20220249771-A1 Lossy mechatronic systems and methods of estimation Pending 13-Jan-2021 000000000
US-20220134338-A1 Diagnostic assay system with replaceable processing modules and remote monitoring Pending 30-Oct-2020 G01N35/00
To view Cepheid’s complete patent history, request access »

Cepheid Executive Team (16)

Name Title Board Seat Contact Info
John Bishop Chairman & Chief Executive Officer
Deborah Gonyea Chief Financial Officer & Senior Vice President
David Persing Ph.D Executive Vice President & Chief Medical and Technology Officer
Jonathan Siegrist Chief Technology Officer
Scott Campbell Ph.D Chief Regulatory Officer, Corporate Vice President, Senior Vice President & General Manager, Oncology
You’re viewing 5 of 16 executive team members. Get the full list »

Cepheid Board Members (8)

Name Representing Role Since
John Bishop Cepheid Chairman & Chief Executive Officer 000 0000
Thomas Gutshall Cepheid Co-Founder & Chairman 000 0000
You’re viewing 2 of 8 board members. Get the full list »

Cepheid Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cepheid Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advanced Technology Ventures Venture Capital Minority 000 0000 000000 0
Band of Angels Angel Group Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
CampVentures Venture Capital Minority 000 0000 000000 0
Innogenetics Corporation Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Cepheid Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Mar-2021 0000000000 Diagnostic Equipment
0000000000 00 01-Oct-2014 000000000 0000 Buildings and Property 0000 0000
00000000 0000 03-Nov-2008 0000000000 00.000 Diagnostic Equipment
0000000 00000 14-Feb-2007 0000000000 0000 Diagnostic Equipment 0000 0000
Actigenics 09-Aug-2006 Merger/Acquisition 00.000 Biotechnology
To view Cepheid’s complete investments and acquisitions history, request access »

Cepheid Subsidiaries (2)

Company Name Industry Location Founded
OncoMark Diagnostic Equipment Dublin, Ireland 2007
00000000 000000000 Diagnostic Equipment Stretton, United Kingdom 0000
To view Cepheid’s complete subsidiaries history, request access »